Evaluation of right and left ventricular volume and ejection fraction using a mathematical cardiac torso phantom.

UNLABELLED: The availability of gated SPECT has increased the interest in the determination of volume and ejection fraction of the left ventricle (LV) for clinical diagnosis. However, the same indices for the right ventricle (RV) have been neglected. The objective of this investigation was to use a mathematical model of the anatomical distribution of activity in gated blood-pool imaging to evaluate the accuracy of two ventricular volume and ejection fraction determination methods. In this investigation, measurements from the RV were emphasized. METHODS: The mathematical cardiac torso phantom, developed to study LV myocardium perfusion, was modified to simulate the radioactivity distribution of a 99mTc-gated blood-pool study. Twenty mathematical cardiac torso phantom models of the normal heart with different LV volumes (122.3 +/- 11.0 ml), RV volumes (174.6 +/- 22.3 ml) and stroke volumes (75.7 +/- 3.3 ml) were randomly generated to simulate variations among patients. An analytical three-dimensional projector with attenuation and system response was used to generate SPECT projection sets, after which noise was added. The projections were simulated for 128 equidistant views in a 360 degrees rotation mode. RESULTS: The radius of rotation was varied between 24 and 28 cm to mimic such variation in patient acquisitions. The 180 degrees and 360 degrees projection sets were reconstructed using the filtered backprojection reconstruction algorithm with Butter-worth filtering. Comparison was made with and without application of the iterative Chang attenuation correction algorithm. Volumes were calculated using a modified threshold and edge detection method (hybrid threshold), as well as a count-based method. A simple background correction procedure was used with both methods. CONCLUSION: Results indicate that cardiac functional parameters can be measured with reasonable accuracy using both methods. However, the count-based method had a larger bias than the hybrid threshold method when RV parameters were determined for 180 degrees reconstruction without attenuation correction. This bias improved after attenuation correction. The count-based method also tended to overestimate the end systolic volume slightly. An improved background correction could possibly alleviate this bias.

Intracoronary Doppler assessment of moderate coronary artery disease: comparison with 201Tl imaging and coronary angiography. FACTS Study Group.

BACKGROUND: Coronary angiography may not reliably predict whether a stenosis causes exercise-induced ischemia. Intracoronary Doppler ultrasound may enhance diagnostic accuracy by providing a physiological assessment of stenosis severity. The goal of this study was to compare intracoronary Doppler ultrasound with both 201Tl imaging and coronary angiography. METHODS AND RESULTS: Fifty-five patients with 67 stenotic coronary arteries underwent coronary angiography with intracoronary Doppler ultrasound and had exercise 201Tl testing within a 1-week period. Coronary flow reserve was measured, and analyses were performed by independent core laboratories. The mean stenosis was 59+/-12%; 51 of 67 stenoses were intermediate in severity (40% to 70%). A coronary flow reserve < 1.7 predicted the presence of a stress 201Tl defect in 56 of 67 stenoses (agreement=84%; kappa=0.67; 95% CI=0.48 to 0.86). In the patients who achieved 75% of their predicted maximum heart rate, the Doppler and 201Tl imaging data agreed in 46 of 52 stenoses (agreement=88%; kappa=0.77; 95%CI=0.57 to 0.97). Scatter was evident when angiography was compared with coronary flow reserve (r=.43), and the angiogram did not reliably predict the results of the 201Tl stress test (kappa=0.21; agreement=57% to 63%). CONCLUSIONS: Doppler-derived coronary flow reserve accurately predicts the presence of exercise-induced ischemia on stress 201Tl imaging, and coronary angiography does not reliably assess the physiological significance of an intermediate coronary stenosis.

Estimation of attenuation maps from scatter and photopeak window single photon-emission computed tomographic images of technetium 99m-labeled sestamibi.

BACKGROUND: In single photon-emission computed tomographic imaging of the chest, nonuniform attenuation correction requires use of a patient-specific attenuation map. The aim of this study was to determine whether an estimate of the regions of the lungs and nonpulmonary tissues of the chest could be obtained by segmenting the photopeak and Compton scatter window images in a phantom and in patients to estimate patient-specific attenuation maps. METHODS AND RESULTS: The photopeak and scatter window slices from 16 consecutive 99mTc-labeled sestamibi perfusion studies were segmented interactively. In these studies, visually reasonable regions could be obtained by estimating a "cold" lung region from scatter window data with additional anatomic information of the myocardium region, the backbone and sternum locations, the liver, and the rib cage from the photopeak window data. In an anthropomorphic torso phantom study and a patient study, comparison was made between the attenuation maps based on segmentation of the emission images and transmission imaging with a slant-hole collimator. It was determined that good agreement in the estimation of the body regions can be achieved with segmentation of the emission images in both the phantom and patient data. Attenuation correction using the maximum-likelihood expectation maximization method was performed on the phantom and the patient data. In both studies, attenuation correction with the segmented attenuation map improved uniformity of the inferior wall region in comparison with the other walls. CONCLUSIONS: The estimation of patient-specific attenuation maps by segmenting the scatter and photopeak window slices of 99mTc-labeled sestamibi studies may be a way of reducing the loss of specificity due to attenuation artifacts. The potential limitations on the accuracy of correction inherent in the method due to the estimation of the regions and assignment of the attenuation coefficients need to be determined further, and the method needs to be further automated before it can be considered for routine clinical use.

Prognostic utility of increased pulmonary thallium uptake in patients without ischemia.

BACKGROUND: Although the combination of increased pulmonary thallium uptake and ischemia has demonstrated prognostic utility, the value of pulmonary uptake independent of ischemia has not been evaluated critically. Accordingly, our purpose was to evaluate the prognostic utility of thallium lung uptake in patients who do not have stress-induced defects. METHODS AND RESULTS: We studied 184 patients who were divided into three groups. Patients with increased pulmonary uptake were grouped into either the normal perfusion (n = 48) or fixed defect (n = 44) scan group and were compared with a third group (n = 92) of control patients who had normal scans and no lung uptake. During a mean follow-up of 23 +/- 13 months, there were 13 cardiac events (death or myocardial infarction) and the incidence per year was 0.6%, 2%, and 12% in the control, normal, and fixed defect groups, respectively (p < 0.00001). Life table analysis demonstrated greater event-free survival rates in the control and normal groups compared with the group with fixed defects. A Cox regression analysis showed that the number of fixed defects (infarct segments) was the most important independent prognostic factor (p < 0.00001) for future cardiac events. CONCLUSION: In patients with increased pulmonary thallium uptake and no stress perfusion defects, the prognosis is similar to that of control patients. However, patients with infarct segments and lung uptake have a significantly worse prognosis.

Transmission imaging of large attenuators using a slant hole collimator on a three-headed SPECT system.

By combining conjugate views, truncation-free attenuation profiles of patients can be obtained by using slant hole collimators on three-headed SPECT systems. The alterations in reconstruction algorithms necessary for use with slant hole collimators and potential image artifacts are discussed. Based on an evaluation of the size of objects that can be imaged without truncation and the size of the overlap region in the conjugate views, a 15 degrees slant angle was determined to be optimal. Studies with a 30 degrees slant hole collimator verified the ability of slant hole transmission imaging to provide accurate, truncation-free attenuation maps of a 56 cm lateral width phantom. The center of rotation was determined to be dependent on the slant angle and radius of rotation of the slant collimator. These studies also demonstrated that the spatial resolution in the transaxial plane of the attenuation maps depends on radius of rotation of the slant hole collimator, but does not depend on the radius of rotation of an uncollimated transmission source. A multiline transmission source was investigated for use with estimating the attenuation map in Tc-99m labeled sestamibi perfusion imaging.

A Monte Carlo investigation of artifacts caused by liver uptake in single-photon emission computed tomography perfusion imaging with technetium 99m-labeled agents.

BACKGROUND: Significant hepatobiliary accumulation of technetium 99m-labeled cardiac perfusion agents has been shown to cause alterations in the apparent localization of the agents in the cardiac walls. A Monte Carlo study was conducted to investigate the hypothesis that the cardiac count changes are due to the inconsistencies in the projection data input to reconstruction, and that correction of the causes of these inconsistencies before reconstruction, or including knowledge of the physics underlying them in the reconstruction algorithm, would virtually eliminate these artifacts. METHODS AND RESULTS: The SIMIND Monte Carlo package was used to simulate 64 x 64 pixel projection images at 128 angles of the three-dimensional mathematical cardiac-torso (MCAT) phantom. Simulations were made of (1) a point source in the liver, (2) cardiac activity only, and (3) hepatic activity only. The planar projections and reconstructed point spread functions (PSFs) of the point source in the liver were investigated to study the nature of the inconsistencies introduced into the projections by imaging, and how these affect the distribution of counts in the reconstructed slices. Bull's eye polar maps of the counts at the center of the left ventricular wall of filtered back-projection (FBP) and maximum-likelihood expectation-maximization (MLEM) reconstructions of projections with solely cardiac activity, and with cardiac activity plus hepatic activity scaled to have twice the cardiac concentration, were compared to determine the magnitude and location of apparent changes in cardiac activity when hepatic activity is present. Separate simulations were made to allow the investigation of stationary spatial resolution, distance-dependent spatial resolution, attenuation, and scatter. The point source projections showed significant inconsistencies as a function of projection angle with the largest effect being caused by attenuation. When consistent projections were simulated, no significant impact of hepatic activity on cardiac counts was noted with FBP, or 100 iterations of MLEM. With inconsistent projections, reconstruction of 180 degrees resulted in greater apparent cardiac count losses than did 360 degrees reconstruction for both FBP and MLEM. The incorporation of attenuation correction in MLEM reconstruction reduced the changes in cardiac counts to that seen in simulations in which attenuation was not included, but resulted in increased apparent localization of activity in the posterior wall of the left ventricle when scatter was present in the simulated images. CONCLUSIONS: The apparent alterations in cardiac counts when significant hepatic localization is present is due to the inconsistency of the projections inherent in imaging. Prior correction of these, or accounting for them in the reconstruction algorithm, will virtually eliminate them as causes of artifactual changes in localization. Attenuation correction and scatter correction are both required to overcome the major sources of apparent count changes in the heart associated with hepatic uptake.

Teboroxime is a marker of reperfusion after myocardial infarction.

BACKGROUND: It has been shown that serial teboroxime imaging can rapidly assess coronary perfusion in viable myocardial distributions. However, the myocardial uptake of teboroxime after reperfusion of acutely infarcted myocardium has not been critically evaluated. The study object was to assess whether teboroxime uptake in acutely infarcted myocardium is linearly related to blood flow. METHODS AND RESULTS: Seventeen New Zealand rabbits underwent occlusion of the left circumflex coronary artery for 1 hour. The animals were reperfused for 2 hours and, just before they were killed, teboroxime was injected. The infarct was delineated by triphenyltetrazolium chloride staining. Normalized blood flow and myocardial teboroxime distribution in the infarcted myocardium was determined by gamma well counting. Ex vivo planar images of the left ventricle were also acquired. Transmural myocardial infarction was documented in all 17 rabbits. The mean infarct size +/- one standard deviation was 25.5% +/- 10.7% (range, 11.9% to 43.3%). There was a direct linear relationship between normalized reperfusion flow and myocardial teboroxime distribution in the infarct zone (r = 0.91). A direct linear relationship between defect size and normalized infarct zone reperfusion was also evident on the ex vivo planar studies (r = 0.70). CONCLUSION: This study shows that the initial uptake of teboroxime in acutely infarcted myocardium is linearly related to blood flow. Teboroxime has properties that are well suited for the early evaluation of infarct zone perfusion.

Arbutamine stress thallium-201 single-photon emission computed tomography using a computerized closed-loop delivery system. Multicenter trial for evaluation of safety and diagnostic accuracy. The International Arbutamine Study Group.

OBJECTIVES: This study sought to evaluate the efficacy and safety of arbutamine when used in conjunction with thallium-201 single-photon emission computed tomography (SPECT) in a multicenter trial and to compare arbutamine stress and treadmill exercise thallium-201 SPECT for diagnostic sensitivity and myocardial perfusion pattern. BACKGROUND: Arbutamine is a potent beta-agonist developed specifically for pharmacologic stress testing. METHODS: Arbutamine was administered by a novel computerized closed-loop device that measures heart rate and adjusts arbutamine infusion to achieve a selected rate of heart rate increase toward a predetermined limit. The cohort included 184 patients who underwent arbutamine stress testing, of whom 122 (catheterization group) had angiographically defined coronary artery disease ( > or = 50% diameter stenosis of a major coronary artery), and 62 had a low pretest likelihood of coronary artery disease (low likelihood group). A subset of 69 patients from the catheterization group underwent both arbutamine and exercise stress testing. RESULTS: Hemodynamic responses during arbutamine and exercise stress testing demonstrated no significant difference in percent increase in heart rate (81% vs. 76%) or systolic blood pressure (26% vs. 30%). The sensitivity for detecting coronary artery disease ( > or = 50% stenosis) using arbutamine thallium-201 SPECT was 87% (95% for detecting > or = 70% stenoses), and the normalcy rate in the low likelihood group was 90%. In patients completing both arbutamine and exercise stress testing, thallium-201 SPECT sensitivity for detecting coronary artery disease ( > or = 50% stenosis) was 94% and 97% (p = NS), respectively Furthermore, SPECT segmental visual score agreement (defect vs. no defect) showed a concordance of 92% between arbutamine and exercise results (kappa 0.80, p < 0.001). The stress thallium-201 SPECT segmental scores showed 83% exact agreement (kappa 0.69, p < 0.001), and analysis of the reversibility of segments with stress perfusion defects demonstrated 86% exact agreement (kappa 0.68, p < 0.001). In general, side effects associated with arbutamine were well tolerated and resolved with discontinuation of infusion. CONCLUSIONS: Arbutamine, administered by a closed-loop feed-back system was shown to be a safe and effective pharmacologic stress agent. Arbutamine stress thallium-201 SPECT appears to be accurate for the diagnosis of coronary artery disease with a diagnostic efficacy similar to that of treadmill exercise thallium-201 studies.

Blood flow velocity in the right coronary artery: assessment before and after angioplasty.

OBJECTIVES: This study attempted 1) to assess the utility of rest measurements of intracoronary blood flow velocity for the physiologic assessment of coronary stenoses before and after right coronary artery angioplasty, and 2) to compare the phasic flow pattern in the right coronary artery proper with the phasic flow pattern in its major branches to the left ventricle. BACKGROUND: Previous investigations have demonstrated that a reduction in distal blood flow velocity and a loss of distal diastolic predominant flow are characteristic of physiologically significant stenoses and that these indexes normalize after successful coronary artery dilation. However, these studies were predominantly performed in the left coronary artery. The utility of monitoring rest velocity variables during angioplasty of the right coronary artery has not been studied. METHODS: We studied 20 patients undergoing angioplasty of the right coronary artery with use of a Doppler angioplasty guide wire. RESULTS: Values were expressed as the mean value +/- 1 SD. The rest average peak velocity did not decrease distal to angiographically significant right coronary artery stenoses (23.3 +/- 9.4 cm/s proximal vs. 20.2 +/- 11.1 cm/s distal, p = 0.20). The proximal/distal velocity ratio was 1.4 +/- 0.9 before angioplasty and did not significantly decrease after angioplasty (p = 0.58). This study had a 99.4% power to detect a difference between proximal and distal average peak velocity. There was no relation between percent diameter stenosis and proximal/distal velocity ratios (r = 0.15, p = 0.55). Diastolic predominant flow was not observed in the proximal or distal right coronary artery. However, after angioplasty, diastolic predominant flow was observed in the posterolateral and posterior descending coronary arteries. CONCLUSIONS: Rest phasic Doppler flow velocity indexes are not useful for evaluating stenoses in the right coronary artery proper before or after angioplasty. In contrast to the right coronary artery proper, diastolic predominant flow is observed in the posterior descending and posterolateral coronary arteries. The utility of measuring hyperemic Doppler flow velocity indexes, such as distal coronary flow reserve, for assessing right coronary artery stenoses merits further investigation.

Use of sequential teboroxime imaging for the detection of coronary artery occlusion and reperfusion in ischemic and infarcted myocardium.

Nine Yorkshire pigs underwent coronary artery occlusion followed by 2 hours of reperfusion. In five pigs (group A) the occlusion time was 15 minutes and in four pigs (group B) the occlusion time was 1 hour. Teboroxime was administered and images were acquired at baseline, and following occlusion and reperfusion. Infarct size was determined by triphenyl tetrazolium staining. Normalized regional myocardial blood flow, as determined by radio-labeled microspheres, was 0.26 +/- 0.09 following occlusion and 0.83 +/- 0.07 following reperfusion (p < 0.01). Significant differences were found between the defect/normal scan ratios on the baseline and occlusion scans (1.0 +/- 0.03 vs 0.54 +/- 0.10; p < 0.01) and between the occlusion and reperfusion scans (0.54 +/- 0.10 vs 0.97 +/- 0.17; p < 0.01). This is the first study to demonstrate that rapid sequential teboroxime imaging can detect acute coronary occlusion and reperfusion to both ischemic and infarcted myocardium. Teboroxime may be an excellent tracer for the early evaluation of infarct artery patency in patients receiving thrombolytic therapy.

Comparison of 3- versus 6-minute infusions of adenosine in thallium-201 myocardial perfusion imaging.

Adenosine thallium stress testing has a demonstrated utility in the detection of coronary artery disease. The optimal dose for diagnostic efficacy with minimal side effects has not been critically evaluated. A randomized 3- and 6-minute infusion of adenosine (140 micrograms/kg/min) was performed in 11 subjects. Subjects reported more side effects during the 6-minute infusion protocol (p < 0.05). Hemodynamic changes were not different during either infusion duration. All dysrhythmias began within 2 minutes and therefore the duration of the infusion did not influence their occurrence. Segmental comparison of the stress images demonstrated an 89% agreement. Delayed scans demonstrated a 79% agreement. There was a higher incidence of redistribution following the 6-minute infusion (p = 0.014). We conclude that when side effects necessitate the discontinuation of a 6-minute adenosine infusion, a diagnostic test can still be achieved if 2 to 3 minutes of adenosine have been administered before the thallium injection; however, the amount of viable myocardium may be underestimated.

Sequential teboroxime imaging during and after balloon occlusion of a coronary artery.

OBJECTIVES: We sought to assess whether sequential teboroxime imaging can rapidly evaluate vessel patency and identify the coronary artery occluded in patients undergoing balloon occlusion of a coronary artery. BACKGROUND: Intravenous thrombolytic therapy results in successful reperfusion of the infarct-related artery in only 50% to 80% of cases. A noninvasive technique to serially evaluate coronary perfusion would identify patients who might benefit from other interventions such as emergency percutaneous transluminal coronary angioplasty, coronary artery bypass grafting or increased intensity of thrombolytic therapy. METHODS: Teboroxime scans were performed during balloon occlusion in 15 nonconsecutive patients undergoing angioplasty of a major coronary artery. Equivalent views were repeated after successful angioplasty. RESULTS: The mean time between balloon occlusion and reperfusion imaging was 1.6 +/- 0.6 h. The mean number of defects decreased significantly from 4.13 +/- 1.01 during balloon occlusion to 0.27 +/- 0.44 after reperfusion (p = 0.0006). There was a 30% decrease in the defect/normal zone count/pixel ratios during balloon occlusion and normalization of these ratios after reperfusion (p = 0.0006). The scans correctly identified all nine left anterior descending coronary artery occlusions and both right coronary artery occlusions. One of the four left circumflex coronary artery occlusions was incorrectly identified as a right coronary artery occlusion by scan criteria. Overall, the scans correctly identified the occluded artery 93% of the time (kappa = 0.88). The scan was 100% accurate for distinguishing occlusion of the left anterior descending coronary artery (n = 9) from occlusions of the left circumflex or right coronary artery (n = 6). CONCLUSIONS: We believe that this is the first clinical study to demonstrate that sequential planar imaging with teboroxime can 1) rapidly detect acute coronary artery occlusion and reperfusion, and 2) identify the occluded coronary artery. A trial comparing rapid sequential teboroxime imaging with coronary angiography in patients receiving thrombolytic therapy for acute myocardial infarction is warranted.

Prediction of late cardiac events by dipyridamole thallium imaging in patients undergoing elective vascular surgery.

Dipyridamole thallium scintigraphy has previously been shown to have prognostic value in the preoperative assessment of patients scheduled to undergo vascular surgery, but its effect on the long-term outcome is less well-defined. In the largest series to date, dipyridamole thallium scanning was performed in 360 patients before elective vascular surgery and survivors were followed for a mean of 31 months. In the 327 patients who underwent vascular surgery, operative death and nonfatal myocardial infarction occurred in 4.9 and 6.7%, respectively. A cardiac event (nonfatal myocardial infarction or cardiac death) occurred in 14.4% of patients with a transient thallium defect, as opposed to 1% with a normal scan (p < 0.001). Logistic regression analysis revealed that the best predictor of a perioperative event was the presence of a reversible thallium defect, elevating the risk by 4.3-fold. Late cardiac events occurred in 53 (15.2%) surgical survivors or nonsurgically treated patients. Patients with a fixed perfusion abnormality had a 24% late event rate, compared with 4.9% in those with a normal dipyridamole thallium study (p < 0.01). Cox analysis demonstrated that a fixed thallium defect was the strongest factor for predicting a late event and increased the relative risk by almost fivefold. A history of congestive heart failure was the only significant variable that contributed additional value to that of a fixed defect alone. Life-table analysis confirmed the strong relation of a fixed defect to cardiac event free survival (p < 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)